Cargando…

Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis

Detalles Bibliográficos
Autores principales: Liao, Jun-Fang, Zhang, Qun, Du, Xiao-Jing, Lan, Mei, Liu, Shan, Xia, Yun-Fei, Cai, Xiu-Yu, Luo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755687/
https://www.ncbi.nlm.nih.gov/pubmed/31547862
http://dx.doi.org/10.1186/s40880-019-0396-2
_version_ 1783453282736275456
author Liao, Jun-Fang
Zhang, Qun
Du, Xiao-Jing
Lan, Mei
Liu, Shan
Xia, Yun-Fei
Cai, Xiu-Yu
Luo, Wei
author_facet Liao, Jun-Fang
Zhang, Qun
Du, Xiao-Jing
Lan, Mei
Liu, Shan
Xia, Yun-Fei
Cai, Xiu-Yu
Luo, Wei
author_sort Liao, Jun-Fang
collection PubMed
description
format Online
Article
Text
id pubmed-6755687
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67556872019-09-26 Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis Liao, Jun-Fang Zhang, Qun Du, Xiao-Jing Lan, Mei Liu, Shan Xia, Yun-Fei Cai, Xiu-Yu Luo, Wei Cancer Commun (Lond) Correction BioMed Central 2019-09-23 /pmc/articles/PMC6755687/ /pubmed/31547862 http://dx.doi.org/10.1186/s40880-019-0396-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Liao, Jun-Fang
Zhang, Qun
Du, Xiao-Jing
Lan, Mei
Liu, Shan
Xia, Yun-Fei
Cai, Xiu-Yu
Luo, Wei
Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
title Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
title_full Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
title_fullStr Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
title_full_unstemmed Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
title_short Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
title_sort correction to: concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755687/
https://www.ncbi.nlm.nih.gov/pubmed/31547862
http://dx.doi.org/10.1186/s40880-019-0396-2
work_keys_str_mv AT liaojunfang correctiontoconcurrentchemoradiotherapywithweeklydocetaxelversuscisplatininthetreatmentoflocoregionallyadvancednasopharyngealcarcinomaapropensityscorematchedanalysis
AT zhangqun correctiontoconcurrentchemoradiotherapywithweeklydocetaxelversuscisplatininthetreatmentoflocoregionallyadvancednasopharyngealcarcinomaapropensityscorematchedanalysis
AT duxiaojing correctiontoconcurrentchemoradiotherapywithweeklydocetaxelversuscisplatininthetreatmentoflocoregionallyadvancednasopharyngealcarcinomaapropensityscorematchedanalysis
AT lanmei correctiontoconcurrentchemoradiotherapywithweeklydocetaxelversuscisplatininthetreatmentoflocoregionallyadvancednasopharyngealcarcinomaapropensityscorematchedanalysis
AT liushan correctiontoconcurrentchemoradiotherapywithweeklydocetaxelversuscisplatininthetreatmentoflocoregionallyadvancednasopharyngealcarcinomaapropensityscorematchedanalysis
AT xiayunfei correctiontoconcurrentchemoradiotherapywithweeklydocetaxelversuscisplatininthetreatmentoflocoregionallyadvancednasopharyngealcarcinomaapropensityscorematchedanalysis
AT caixiuyu correctiontoconcurrentchemoradiotherapywithweeklydocetaxelversuscisplatininthetreatmentoflocoregionallyadvancednasopharyngealcarcinomaapropensityscorematchedanalysis
AT luowei correctiontoconcurrentchemoradiotherapywithweeklydocetaxelversuscisplatininthetreatmentoflocoregionallyadvancednasopharyngealcarcinomaapropensityscorematchedanalysis